Loading...
Guardant Health, Inc.
GH•NASDAQ
Healthcare
Medical - Diagnostics & Research
$44.42
$-1.07(-2.35%)
Guardant Health, Inc. (GH) Financial Performance & Income Statement Overview
Review Guardant Health, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
31.04%
↑ 31.04%
Operating Income Growth
21.45%
↑ 21.45%
Net Income Growth
8.98%
↑ 8.98%
Operating Cash Flow Growth
26.19%
↑ 26.19%
Operating Margin
-58.78%
↓ 58.78%
Gross Margin
61.34%
↑ 61.34%
Net Profit Margin
-53.82%
↓ 53.82%
ROE
368.51%
↑ 368.51%
ROIC
-40.68%
↓ 40.68%
Guardant Health, Inc. (GH) Income Statement & Financial Overview
Review Guardant Health, Inc.'s (GH) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $201.81M | $191.48M | $177.24M | $168.49M |
| Cost of Revenue | $77.59M | $74.49M | $72.42M | $65.30M |
| Gross Profit | $124.22M | $116.99M | $104.81M | $103.19M |
| Gross Profit Ratio | $0.62 | $0.61 | $0.59 | $0.61 |
| R&D Expenses | $93.54M | $87.31M | $83.10M | $83.80M |
| SG&A Expenses | $156.64M | $147.009M | $122.33M | $119.08M |
| Operating Expenses | $250.19M | $234.31M | $205.43M | $202.88M |
| Total Costs & Expenses | $327.78M | $308.80M | $277.85M | $268.17M |
| Interest Income | $11.65M | $13.26M | $13.91M | $14.87M |
| Interest Expense | $645000.00 | $646000.00 | $645000.00 | $645000.00 |
| Depreciation & Amortization | $10.45M | $10.60M | $10.70M | $10.71M |
| EBITDA | -$99.19M | -$96.48M | -$91.15M | -$103.22M |
| EBITDA Ratio | -$0.49 | -$0.50 | -$0.51 | -$0.61 |
| Operating Income | -$125.97M | -$117.33M | -$100.62M | -$99.68M |
| Operating Income Ratio | -$0.62 | -$0.61 | -$0.57 | -$0.59 |
| Other Income/Expenses (Net) | $15.68M | $9.60M | -$1.88M | -$14.90M |
| Income Before Tax | -$110.29M | -$107.72M | -$102.50M | -$114.58M |
| Income Before Tax Ratio | -$0.55 | -$0.56 | -$0.58 | -$0.68 |
| Income Tax Expense | $716000.00 | $30000.00 | $133000.00 | $405000.00 |
| Net Income | -$111.006M | -$107.75M | -$102.63M | -$114.98M |
| Net Income Ratio | -$0.55 | -$0.56 | -$0.58 | -$0.68 |
| EPS | -$0.90 | -$0.88 | -$0.84 | -$0.94 |
| Diluted EPS | -$0.90 | -$0.88 | -$0.84 | -$0.94 |
| Weighted Avg Shares Outstanding | $123.75M | $123.05M | $122.45M | $121.71M |
| Weighted Avg Shares Outstanding (Diluted) | $123.75M | $123.05M | $122.45M | $121.71M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan